AAAAAA

   
Results: 1-25 | 26-32
Results: 1-25/32
RANDOMIZED COMPARISON OF DIRECT THROMBIN INHIBITION VERSUS HEPARIN INCONJUNCTION WITH FIBRINOLYTIC THERAPY FOR ACUTE MYOCARDIAL-INFARCTION- RESULTS FROM THE GUSTO-IIB TRIAL
Authors: METZ BK WHITE HD GRANGER CB SIMES RJ ARMSTRONG PW HIRSH J FUSTER V MACAULAY CM CALIFF RM TOPOL EJ
Citation: Bk. Metz et al., RANDOMIZED COMPARISON OF DIRECT THROMBIN INHIBITION VERSUS HEPARIN INCONJUNCTION WITH FIBRINOLYTIC THERAPY FOR ACUTE MYOCARDIAL-INFARCTION- RESULTS FROM THE GUSTO-IIB TRIAL, Journal of the American College of Cardiology, 31(7), 1998, pp. 1493-1498
PRAVASTATIN REDUCES TOTAL MORTALITY IN PATIENTS WITH CORONARY HEART-DISEASE AND AVERAGE CHOLESTEROL LEVELS - RELATIONSHIP OF BASE-LINE CHOLESTEROL AND TREATMENT EFFECTS IN THE LIPID TRIAL
Authors: SIMES RJ BAKER J MACMAHON S HAGUE W COLQUHOUN D WEST M ARULCHELVAM M SHAW J TONKIN A
Citation: Rj. Simes et al., PRAVASTATIN REDUCES TOTAL MORTALITY IN PATIENTS WITH CORONARY HEART-DISEASE AND AVERAGE CHOLESTEROL LEVELS - RELATIONSHIP OF BASE-LINE CHOLESTEROL AND TREATMENT EFFECTS IN THE LIPID TRIAL, Journal of the American College of Cardiology, 31(2), 1998, pp. 281-281
THE LIPID TRIAL - IMPACT OF LIPID-LOWERING THERAPY WITH PRAVASTATIN ON THE RISK OF STROKE
Authors: WHITE HD SIMES RJ WATSON J ANDERSON N HANKEY G SIMES S TONKIN A
Citation: Hd. White et al., THE LIPID TRIAL - IMPACT OF LIPID-LOWERING THERAPY WITH PRAVASTATIN ON THE RISK OF STROKE, Journal of the American College of Cardiology, 31(2), 1998, pp. 282-282
PRACTICAL APPROACHES TO MINIMIZE PROBLEMS WITH MISSING QUALITY-OF-LIFE DATA
Authors: SIMES RJ GREATOREX V GEBSKI VJ
Citation: Rj. Simes et al., PRACTICAL APPROACHES TO MINIMIZE PROBLEMS WITH MISSING QUALITY-OF-LIFE DATA, Statistics in medicine, 17(5-7), 1998, pp. 725-737
QUALITY-ADJUSTED SURVIVAL ANALYSIS WITH REPEATED QUALITY-OF-LIFE MEASURES
Authors: GLASZIOU PP COLE BF GELBER RD HILDEN J SIMES RJ
Citation: Pp. Glasziou et al., QUALITY-ADJUSTED SURVIVAL ANALYSIS WITH REPEATED QUALITY-OF-LIFE MEASURES, Statistics in medicine, 17(11), 1998, pp. 1215-1229
COST-EFFECTIVENESS OF PRAVASTATIN IN PATIENTS WITH CORONARY HEART-DISEASE AND AVERAGE CHOLESTEROL LEVELS
Authors: GLASZIOU PP MULRAY SE HALL JP MARTIN A HARRIS P THOMPSON P TONKIN A SIMES RJ
Citation: Pp. Glasziou et al., COST-EFFECTIVENESS OF PRAVASTATIN IN PATIENTS WITH CORONARY HEART-DISEASE AND AVERAGE CHOLESTEROL LEVELS, Medical decision making, 18(4), 1998, pp. 475-475
PREVENTION OF CARDIOVASCULAR EVENTS AND DEATH WITH PRAVASTATIN IN PATIENTS WITH CORONARY HEART-DISEASE AND A BROAD RANGE OF INITIAL CHOLESTEROL LEVELS
Authors: TONKIN A AYLWARD P COLQUHOUN D GLASZIOU P HARRIS P MACMAHON S MAGNUS P NEWEL D NESTEL P SHARPE N HUNT D SHAW J SIMES RJ THOMPSON P THOMSON A WEST M WHITE H SIMES S HAGUE W CALEO S HALL J MARTIN A MULRAY S BARTER P BEILIN L COLLINS R MCNEIL J MEIER P WILLIMOTT H SMITHERS D WALLACE P SULLIVAN D KEECH A
Citation: A. Tonkin et al., PREVENTION OF CARDIOVASCULAR EVENTS AND DEATH WITH PRAVASTATIN IN PATIENTS WITH CORONARY HEART-DISEASE AND A BROAD RANGE OF INITIAL CHOLESTEROL LEVELS, The New England journal of medicine, 339(19), 1998, pp. 1349-1357
INTERVENTION WITH PTCA AND CABG FOLLOWING THROMBOLYSIS FOR ACUTE MYOCARDIAL-INFARCTION - AUSTRALIAN DATA FROM GUSTO 1 (1991-3) AND INTERNATIONAL STUDY-GROUP R-TPA-STREPTOKINASE MORTALITY (1989) TRIALS
Authors: TIDEMAN PA FABRI JK AYLWARD PE SIMES RJ
Citation: Pa. Tideman et al., INTERVENTION WITH PTCA AND CABG FOLLOWING THROMBOLYSIS FOR ACUTE MYOCARDIAL-INFARCTION - AUSTRALIAN DATA FROM GUSTO 1 (1991-3) AND INTERNATIONAL STUDY-GROUP R-TPA-STREPTOKINASE MORTALITY (1989) TRIALS, Australian and New Zealand Journal of Medicine, 28(4), 1998, pp. 533-540
PUBLICATION BIAS - EVIDENCE OF DELAYED PUBLICATION IN A COHORT STUDY OF CLINICAL RESEARCH PROJECTS
Authors: STERN JM SIMES RJ
Citation: Jm. Stern et Rj. Simes, PUBLICATION BIAS - EVIDENCE OF DELAYED PUBLICATION IN A COHORT STUDY OF CLINICAL RESEARCH PROJECTS, BMJ. British medical journal, 315(7109), 1997, pp. 640-645
IMPROVED QUALITY-OF-LIFE WITH MEGESTROL-ACETATE IN PATIENTS WITH ENDOCRINE-INSENSITIVE ADVANCED CANCER - A RANDOMIZED PLACEBO-CONTROLLED TRIAL
Authors: BELLER E TATTERSALL M LUMLEY T LEVI J DALLEY D OLVER I PAGE J ABDI E WYNNE C FRIEDLANDER M BOADLE D WHEELER H MARGRIE S SIMES RJ
Citation: E. Beller et al., IMPROVED QUALITY-OF-LIFE WITH MEGESTROL-ACETATE IN PATIENTS WITH ENDOCRINE-INSENSITIVE ADVANCED CANCER - A RANDOMIZED PLACEBO-CONTROLLED TRIAL, Annals of oncology, 8(3), 1997, pp. 277-283
COMBINING IIB IIIA INHIBITION AND HEPARIN FOR ACUTE CORONARY SYNDROMES - EVIDENCE OF A GRADIENT FOR BLEEDING HAZARD FROM THE PARAGON RANDOMIZED FACTORIALLY DESIGNED TRIAL/
Authors: HARRINGTON RA NEWBY LK MOLITERNO DJ BHAPKAR M ARMSTRONG PW SIMES RJ WHITE HD VANDEWERF F RAMES A TOPOL EJ CALIFF RM
Citation: Ra. Harrington et al., COMBINING IIB IIIA INHIBITION AND HEPARIN FOR ACUTE CORONARY SYNDROMES - EVIDENCE OF A GRADIENT FOR BLEEDING HAZARD FROM THE PARAGON RANDOMIZED FACTORIALLY DESIGNED TRIAL/, Journal of the American College of Cardiology, 29(2), 1997, pp. 3338-3338
MEDROXYPROGESTERONE ACETATE ADDITION OR SUBSTITUTION FOR TAMOXIFEN INADVANCED TAMOXIFEN-RESISTANT BREAST-CANCER - A PHASE-III RANDOMIZED TRIAL
Authors: BYRNE MJ GEBSKI V FORBES J TATTERSALL MHN SIMES RJ COATES AS DEWAR J LUNN M FLOWER C GILL PG STEWART J
Citation: Mj. Byrne et al., MEDROXYPROGESTERONE ACETATE ADDITION OR SUBSTITUTION FOR TAMOXIFEN INADVANCED TAMOXIFEN-RESISTANT BREAST-CANCER - A PHASE-III RANDOMIZED TRIAL, Journal of clinical oncology, 15(9), 1997, pp. 3141-3148
EFFECTIVENESS OF ADJUVANT CHEMOTHERAPY IN COMBINATION WITH TAMOXIFEN FOR NODE-POSITIVE POSTMENOPAUSAL BREAST-CANCER PATIENTS
Authors: CASTIGLIONEGERTSCH M GOLDHIRSCH A GUSTERSON B BETTELHEIM R REED R GUSSET H GEISER K HURNY C BERNHARD J HANGARTNER A MAIBACH R PEDOWSKI R GELBER R PRICE K PETERSON H ZELEN M ISLEY M HINKLE R KAY RG HOLDAWAY IM HARVEY VJ JAGUSCH MF NEAVE L MASON BM EVANS B BENJAMIN CS CARTER JF GILLMAN JC MACK D BENSONCOOPER D MONFARDINI S GALLIGIONI E CRIVELLARI D BUONADONNA A MASSARUT S ROSSI C CANDIANI E CARBONE A VOLPE R TROVO MG RONCADIN M SANTINI GF VILLALTA D CORAN F MORASSUT S MARINI G SIMONCINI E MARPICATI P ZANIBONI A SARTORI U BARNI A CERUTTI L ALGHISI A RAFFAGLIO E GARATTINI MP ALBERTINI A GRIGOLATO F MORASSI L BERGONZINI R LAURIOLA C GUDGEON A DENT DM TILTMAN A HACKING A DOWDLE E STEYNOR P TOOP J SCHNURCH HG MOSNY D BENDER HG BOJAR H VERONESI A FOLADORE S PAMICH G BIANCHI G TORRETTA A RUDENSTAM CM WALLGREN A PERSSON S MATTSSON J CAHLIN E HAFSTROM LO HOLMBERG S HULTBORN R COLLDAHLJADERSTROM G GUSTAVSSON B CARLSSON G IVARSSON L THOREN O RUUSVIK O NICKLASSON LG DAHLIN S KARLSSON G LINDBERG B SUNDBACK A BERGEGARDH S SALANDER H ANDERSSON C HESSMAN Y NELZEN O HEIDEMAN M RAMHULT T SVENSSON JH LIDBERG P BJORK S LINDTNER J ERZEN D CERAR O STABUC B GOLOUH R LAMOVEC J SEBEK S KRAMBERGER M VRHOVEC I CORTESFUNES H MARTINEZTELLO F MENDIOLA C CRUZVIGO F LARRODERA ML SIERRA A MIRANDA P ALONSO S COLLINS J SNYDER R GREGORY P BURAS WI GREEN M GALE T HENDERSON M HART S NEIL S KITCHEN P LOVELL R MCLENNAN R REED R RUSSELL I SCHWARZ M BASSER R ROBERTSON A GILL P CARTER ML MALYCHA P YEOH E WARD G LEONG ASY LOMMAXSMITH J HOOSFALL D DANGELO R BYRNE M VANHAZEL G DEWAR J BUCK M SHEINER HJ INGRAM D STERRETT G HAHNEL R FORBES JF STEWARD J DARBAR SW BISHOP JM SIMMS B ZIOGAS V TATTERSALL MHN COATES A NIESCHE F WEST R RENWICK S DONOVAN J DUVAL P SIMES RJ NG A GLENN D NORTH RA BEITH J OCONNOR RG RICE M STEVENS G FEY M BARTH A DREHER E ISENSCHMID M SCHNEIDER H BUSER K LUDIN J LUTHI JM ALTERMATT HJ LAISSUE JA MARKWALDER R BURGI H SENN HJ THURLIMANN B JUNGI WF MORANT R OEHLSCHLEGEL C HARDMEIER T LUSCHER K RIES G TOPFER M LORENZ U BENZ D SCHILTKNECHT O SPATI B SCHMID L CAVALLI F SESSA C BRONZ L MARTINELLI G MULLER W LUSCIETI P PASSEGA E PEDRINIS E REY P MARTINOLI S SPINELLI A GALFETTI MA LOMBARDI A PEDRAZZINI A LOSA G VARINI M GINIER M HERRMANN R HARDER JF LAFFER U ALMENDRAL AC EPPENBERGER U TORHORST J SIEGENTHALER P PIGUET D BARRELET V BAUMANN RP JOSS R SAUTER C METZGER U ENGELER V HALLER U KOCHLI O LEYVRAZ S PEREY L ANANI P GOMEZ F MIRIMANOFF RO CHAPUIS G DEGRANDI P REYMOND P ALBERTO P SCHAFER P KRAUER F FORNI M AAPRO M EGELI R MEGEVAND R JACOTDESCOMBES E SCHINDLER A NOSEDA G WEBER W LEHMANN W
Citation: M. Castiglionegertsch et al., EFFECTIVENESS OF ADJUVANT CHEMOTHERAPY IN COMBINATION WITH TAMOXIFEN FOR NODE-POSITIVE POSTMENOPAUSAL BREAST-CANCER PATIENTS, Journal of clinical oncology, 15(4), 1997, pp. 1385-1394
DESIGN OF A COST-EFFECTIVENESS STUDY WITHIN A RANDOMIZED TRIAL - THE LIPID TRIAL FOR SECONDARY PREVENTION OF IHD
Authors: GLASZIOU PP SIMES RJ HALL J DONALDSON C
Citation: Pp. Glasziou et al., DESIGN OF A COST-EFFECTIVENESS STUDY WITHIN A RANDOMIZED TRIAL - THE LIPID TRIAL FOR SECONDARY PREVENTION OF IHD, Controlled clinical trials, 18(5), 1997, pp. 464-476
COMPARISON OF PRIMARY CORONARY ANGIOPLASTY AND INTRAVENOUS THROMBOLYTIC THERAPY FOR ACUTE MYOCARDIAL-INFARCTION - A QUANTITATIVE REVIEW
Authors: WEAVER WD SIMES RJ BETRIU A GRINES CL ZIJLSTRA F GARCIA E GRINFELD L GIBBONS RJ RIBEIRO EE DEWOOD MA RIBICHINI F
Citation: Wd. Weaver et al., COMPARISON OF PRIMARY CORONARY ANGIOPLASTY AND INTRAVENOUS THROMBOLYTIC THERAPY FOR ACUTE MYOCARDIAL-INFARCTION - A QUANTITATIVE REVIEW, JAMA, the journal of the American Medical Association, 278(23), 1997, pp. 2093-2098
AMPLIFICATION OF CLINICAL BENEFIT AT 6 MONTHS WITH THE GLYCOPROTEIN IIB IIIA INHIBITOR LAMIFIBAN IN PATIENTS WITH NON ST SEGMENT ELEVATION ACUTE CORONARY SYNDROMES/
Authors: HARRINGTON RA MOLITERNO DJ NEWBY K ARMSTRONG PW VANDEWERF FJ SIMES RJ RAMES A BHAPKAR M CALIFF RM KEECH A TOPOL EJ
Citation: Ra. Harrington et al., AMPLIFICATION OF CLINICAL BENEFIT AT 6 MONTHS WITH THE GLYCOPROTEIN IIB IIIA INHIBITOR LAMIFIBAN IN PATIENTS WITH NON ST SEGMENT ELEVATION ACUTE CORONARY SYNDROMES/, Circulation, 96(8), 1997, pp. 2645-2645
DOES THE EARLY HAZARD PHENOMENON EXIST - DO THE GUSTO FINDINGS PROVE OR DISPROVE - RESPONSE
Authors: SIMES RJ KLEIMAN NS CALIFF RM TOPOL EJ
Citation: Rj. Simes et al., DOES THE EARLY HAZARD PHENOMENON EXIST - DO THE GUSTO FINDINGS PROVE OR DISPROVE - RESPONSE, Circulation, 96(10), 1997, pp. 3780-3781
SELECTION OF THROMBOLYTIC THERAPY FOR INDIVIDUAL PATIENTS - DEVELOPMENT OF A CLINICAL-MODEL
Authors: CALIFF RM WOODLIEF LH HARRELL FE LEE KL WHITE HD GUERCI A BARBASH GI SIMES RJ WEAVER WDD SIMOONS ML TOPOL EJ
Citation: Rm. Califf et al., SELECTION OF THROMBOLYTIC THERAPY FOR INDIVIDUAL PATIENTS - DEVELOPMENT OF A CLINICAL-MODEL, The American heart journal, 133(6), 1997, pp. 630-639
IMPACT OF HIRUDIN VERSUS HEPARIN ON MORTALITY AND (RE)INFARCTION IN PATIENTS WITH ACUTE CORONARY SYNDROMES - A PROSPECTIVE METAANALYSIS OF THE GUSTO-IIB AND TIMI 9B TRIALS
Authors: SIMES RJ GRANGER CB ANTMAN EM CALIFF RM BRAUNWALD E TOPOL EJ
Citation: Rj. Simes et al., IMPACT OF HIRUDIN VERSUS HEPARIN ON MORTALITY AND (RE)INFARCTION IN PATIENTS WITH ACUTE CORONARY SYNDROMES - A PROSPECTIVE METAANALYSIS OF THE GUSTO-IIB AND TIMI 9B TRIALS, Circulation, 94(8), 1996, pp. 2507-2507
AGE AND OUTCOME WITH CONTEMPORARY THROMBOLYTIC THERAPY - RESULTS FROMTHE GUSTO-I TRIAL
Authors: WHITE HD BARBASH GI CALIFF RM SIMES RJ GRANGER CB WEAVER WD KLEIMAN NS AYLWARD PE GORE JM VAHANIAN A LEE KL ROSS AM TOPOL EJ
Citation: Hd. White et al., AGE AND OUTCOME WITH CONTEMPORARY THROMBOLYTIC THERAPY - RESULTS FROMTHE GUSTO-I TRIAL, Circulation, 94(8), 1996, pp. 1826-1833
ONE-YEAR RESULTS FROM THE GLOBAL UTILIZATION OF STREPTOKINASE AND TPAFOR OCCLUDED CORONARY-ARTERIES (GUSTO-I) TRIAL
Authors: CALIFF RM WHITE HD VANDEWERF EV SADOWSKI Z ARMSTRONG PW VAHANIAN A SIMOONS ML SIMES RJ LEE KL TOPOL EJ
Citation: Rm. Califf et al., ONE-YEAR RESULTS FROM THE GLOBAL UTILIZATION OF STREPTOKINASE AND TPAFOR OCCLUDED CORONARY-ARTERIES (GUSTO-I) TRIAL, Circulation, 94(6), 1996, pp. 1233-1238
ENERGY GAPS IN STRAINED IN1-XGAXAS IN1-YGAYASZP1-Z QUANTUM-WELLS GROWN ON (001)INP/
Authors: WEIHOFEN R WEISER G STARCK C SIMES RJ
Citation: R. Weihofen et al., ENERGY GAPS IN STRAINED IN1-XGAXAS IN1-YGAYASZP1-Z QUANTUM-WELLS GROWN ON (001)INP/, Physical review. B, Condensed matter, 51(7), 1995, pp. 4296-4305
VARIATIONS IN PATIENT-MANAGEMENT AND OUTCOMES FOR ACUTE MYOCARDIAL-INFARCTION IN THE UNITED-STATES AND OTHER COUNTRIES - RESULTS FROM THE GUSTO TRIAL
Authors: VANDEWERF F TOPOL EJ LEE KL WOODLIEF LH GRANGER CB ARMSTRONG PW BARBASH GI HAMPTON JR GUERCI A SIMES RJ ROSS AM CALIFF RM
Citation: F. Vandewerf et al., VARIATIONS IN PATIENT-MANAGEMENT AND OUTCOMES FOR ACUTE MYOCARDIAL-INFARCTION IN THE UNITED-STATES AND OTHER COUNTRIES - RESULTS FROM THE GUSTO TRIAL, JAMA, the journal of the American Medical Association, 273(20), 1995, pp. 1586-1591
LINK BETWEEN THE ANGIOGRAPHIC SUBSTUDY AND MORTALITY OUTCOMES IN A LARGE RANDOMIZED TRIAL OF MYOCARDIAL REPERFUSION - IMPORTANCE OF EARLY AND COMPLETE INFARCT ARTERY REPERFUSION
Authors: SIMES RJ TOPOL EJ HOLMES DR WHITE HD RUTSCH WR VAHANIAN A SIMOONS ML MORRIS D BETRIU A CALIFF RM ROSS AM
Citation: Rj. Simes et al., LINK BETWEEN THE ANGIOGRAPHIC SUBSTUDY AND MORTALITY OUTCOMES IN A LARGE RANDOMIZED TRIAL OF MYOCARDIAL REPERFUSION - IMPORTANCE OF EARLY AND COMPLETE INFARCT ARTERY REPERFUSION, Circulation, 91(7), 1995, pp. 1923-1928
PROSPECTIVE METAANALYSIS OF CHOLESTEROL-LOWERING STUDIES - THE PROSPECTIVE PRAVASTATIN POOLING (PPP) PROJECT AND THE CHOLESTEROL TREATMENT TRIALISTS (CTT) COLLABORATION
Authors: SIMES RJ
Citation: Rj. Simes, PROSPECTIVE METAANALYSIS OF CHOLESTEROL-LOWERING STUDIES - THE PROSPECTIVE PRAVASTATIN POOLING (PPP) PROJECT AND THE CHOLESTEROL TREATMENT TRIALISTS (CTT) COLLABORATION, The American journal of cardiology, 76(9), 1995, pp. 122-126
Risultati: 1-25 | 26-32